Li SQ - Search Results

1

Long Intergenic Nonprotein Coding RNA 0152 Promotes Hepatocellular Carcinoma Progression by Regulating Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Pathway through miR-139/PIK3CA.

Li SQ, Chen Q, Qin HX, Yu YQ, Weng J, Mo QR, Yin XF, Lin Y, Liao WJ. Li SQ, et al. Am J Pathol. 2020 May;190(5):1095-1107. doi: 10.1016/j.ajpath.2019.11.010. Epub 2020 Jan 16. Am J Pathol. 2020. PMID: 31954697 Free article.

2

Aflatoxin B1 promotes cell growth and invasion in hepatocellular carcinoma HepG2 cells through H19 and E2F1.

Lv J, Yu YQ, Li SQ, Luo L, Wang Q. Lv J, et al. Among authors: li sq. Asian Pac J Cancer Prev. 2014;15(6):2565-70. doi: 10.7314/apjcp.2014.15.6.2565. Asian Pac J Cancer Prev. 2014. PMID: 24761865 Free article.

3

Upregulation of colonic and hepatic tumor overexpressed gene is significantly associated with the unfavorable prognosis marker of human hepatocellular carcinoma.

Yu JX, Chen Q, Yu YQ, Li SQ, Song JF. Yu JX, et al. Among authors: li sq. Am J Cancer Res. 2016 Feb 15;6(3):690-700. eCollection 2016. Am J Cancer Res. 2016. PMID: 27152245 Free PMC article.

4

MiR-675 Promotes the Growth of Hepatocellular Carcinoma Cells Through the Cdc25A Pathway.

Yu YQ, Weng J, Li SQ, Li B, Lv J. Yu YQ, et al. Among authors: li sq, li b. Asian Pac J Cancer Prev. 2016;17(8):3881-5. Asian Pac J Cancer Prev. 2016. PMID: 27644634 Free article.

5

HNF1A/CASC2 regulates pancreatic cancer cell proliferation through PTEN/Akt signaling.

Yu Y, Liang S, Zhou Y, Li S, Li Y, Liao W. Yu Y, et al. J Cell Biochem. 2019 Mar;120(3):2816-2827. doi: 10.1002/jcb.26395. Epub 2018 Nov 30. J Cell Biochem. 2019. PMID: 28865121

6

Prediction of early treatment response to the combination therapy of TACE plus lenvatinib and anti-PD-1 antibody immunotherapy for unresectable hepatocellular carcinoma: Multicenter retrospective study.

Li S, Wu J, Wu J, Fu Y, Zeng Z, Li Y, Li H, Liao W, Yan M. Li S, et al. Front Immunol. 2023 Feb 17;14:1109771. doi: 10.3389/fimmu.2023.1109771. eCollection 2023. Front Immunol. 2023. PMID: 36875116 Free PMC article.

7

Radiomics model based on contrast-enhanced computed tomography to predict early recurrence in patients with hepatocellular carcinoma after radical resection.

Li SQ, Su LL, Xu TF, Ren LY, Chen DB, Qin WY, Yan XZ, Fan JX, Chen HS, Liao WJ. Li SQ, et al. World J Gastroenterol. 2023 Jul 14;29(26):4186-4199. doi: 10.3748/wjg.v29.i26.4186. World J Gastroenterol. 2023. PMID: 37475840 Free PMC article.

8

Nomogram for predicting severe abdominal pain after initial conventional transarterial chemoembolisation for hepatocellular carcinoma: a retrospective study.

Qin H, Xiao X, Ya H, Li J, Liang F, Jin H, Liao L, Li Y, Qin J, Yu J, Gu J, Zhou C, Jin M, Miao Y, Li S. Qin H, et al. Sci Rep. 2023 Dec 16;13(1):22397. doi: 10.1038/s41598-023-49509-z. Sci Rep. 2023. PMID: 38104191 Free PMC article.

9

LncRNA H19 Activates the RAS-MAPK Signaling Pathway via miR-140-5p/SOS1 Axis in Malignant Liver Tumors.

Yu YQ, Li SQ, Weng J, Li B, Qin LL, Lv J. Yu YQ, et al. Among authors: li sq, li b. Curr Med Sci. 2024 Dec;44(6):1232-1240. doi: 10.1007/s11596-024-2949-0. Epub 2024 Nov 20. Curr Med Sci. 2024. PMID: 39565504

10

Efficacy and Safety of Lenvatinib Plus Programmed Death-1 Inhibitors with or Without Transarterial Chemoembolization in the Treatment of Unresectable Hepatocellular Carcinoma.

Jin M, Jiang ZQ, Qin JH, Qin HX, Jiang KW, Ya HX, Gu J, Gui MR, Li YH, Xu LK, Fu HX, Xiao XH, Li SQ. Jin M, et al. Among authors: li sq. J Hepatocell Carcinoma. 2024 Nov 25;11:2309-2320. doi: 10.2147/JHC.S485047. eCollection 2024. J Hepatocell Carcinoma. 2024. PMID: 39619601 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,076 results

Search Page

Filters